1Mercadante S,Gebbia V,Marrazzo A,et al.Anaemia in cancer:pathophysiology and treatment[J].Cancer Treat Rev,2000,26(4):303-311
2Smaniotto D,Luzi S,Morganti AG,et al.prognostic significance of anemia and orle of erythropoietin in radiation therapy [J].Tumori,2000,86(1):17-23
3Glaser CM,Millesi W,Kornek GV,et al.Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy of for squamous cell carcinoma of the oral cavity and oropharynx [J].Int J Radiat Oncol Biol Phys,2001,
4Kasper C,Terhaar A,Fossa A,et al.Recombinant human erythropoietin in the treatment of cancer-related anaemia [J].Eur J Haematol,1997,58(4):251-256
5Ludwig H,Fritz E.Anemia of cancer patients: patient selection and patient stratification for epoetin treatment [J].Semin Oncol,1998,25(3):35-38
6Gabrilove JL,Cleeland CS,Livingston RB,et al.Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are simiar to three-times-weekly dosing [J].J Glin Oncol,2001,19 (11):2875 ～28
7Cella D,Bron D.The effect of Epoetin alfa on quality of life in anemic cancer patients[J].Cancer Pract,1997,7(4):177-182
8Aoki I,Higashi K,Homori M,et al,Responsiveness of bone marrow ereythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin in vitro in aplastic anemia and myelodysplastic syndrome[J].AmJ Hematol,1990,35(1):6～12
10Caro J J, Salas M, Ward A, et al. Anemia as an independent prog-nostic factor for survival in patients with cancer: A systemic, quali- tative review[J]. Cancer, 2001,91 : 2 214-2 221.
